MARKET

CERT

CERT

Certara, Inc.
NASDAQ
7.29
+0.23
+3.19%
Opening 15:09 07/16 EDT
OPEN
7.12
PREV CLOSE
7.06
HIGH
7.40
LOW
7.02
VOLUME
2.12M
TURNOVER
--
52 WEEK HIGH
13.88
52 WEEK LOW
4.450
MARKET CAP
1.13B
P/E (TTM)
-76.5231
1D
5D
1M
3M
1Y
5Y
1D
Certara (CERT) Taps NVIDIA For AI Drug Development, Is It A Bargain?
Simply Wall St · 2d ago
Weekly Report: what happened at CERT last week (0706-0710)?
Weekly Report · 3d ago
Consumer Tech News (July 6-10): Micron Plans $250B US Expansion, Apple Signs $30B Broadcom Deal & More
Benzinga · 4d ago
What Certara (CERT)'s NVIDIA BioNeMo Partnership Means For Shareholders
Simply Wall St · 07/09 18:45
Analysts Conflicted on These Healthcare Names: Certara (CERT), Nurix Therapeutics (NRIX) and Vertex Pharmaceuticals (VRTX)
TipRanks · 07/08 13:40
Certara, Silo Pharma Advance AI Agent Strategies with Nvidia Initiatives
Benzinga · 07/07 18:18
Certara partners with Nvidia to advance open integrated AI platform
TipRanks · 07/07 12:26
Certara partners with NVIDIA to integrate BioNeMo Agent Toolkit into AI drug development platform
PUBT · 07/07 12:05
More
About CERT
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.